Bumetanide - NDC Database (Page 10)
83301-0080 Aug 12, 2025
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Mullan Pharmaceutical Inc.
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Mullan Pharmaceutical Inc.
83301-0081 Jan 09, 2026
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Mullan Pharmaceutical Inc.
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Mullan Pharmaceutical Inc.
83854-007 Feb 27, 2026
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection, Solution by Anthea Pharma Private Limited
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection, Solution by Anthea Pharma Private Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.